Concepedia

Luigi Del Pozzo

LD

12

Publications

764

Citations

11

H-Index

2008

Active since

Affiliations

University Medical Center Freiburg(Current)

Deutschen Konsortium für Translationale Krebsforschung

German Cancer Research Center

Heidelberg University

University Hospital of Basel

Luigi Del Pozzo is an author at University Medical Center Freiburg specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2008–2024

12

Publications

12

PET of Somatostatin Receptor–Positive Tumors Using <sup>64</sup>Cu- and <sup>68</sup>Ga-Somatostatin Antagonists: The Chelate Makes the Difference

Melpomeni Fani, Luigi Del Pozzo, K. Abiraj et al. · Journal of Nuclear Medicine · 2011 · 255 citations

Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study

Damian Wild, Melpomeni Fani, Richard Fischer et al. · Journal of Nuclear Medicine · 2014 · 255 citations · Full text

Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer

Eleni Gourni, Luigi Del Pozzo, Emilie Kheirallah et al. · Molecular Pharmaceutics · 2015 · 51 citations

, , +17

The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model

Svetlana N. Rylova, C. Stoykow, Luigi Del Pozzo et al. · PLoS ONE · 2018 · 46 citations · Full text

, , +26

Immuno-PET Imaging of CD30-Positive Lymphoma Using <sup>89</sup>Zr-Desferrioxamine–Labeled CD30-Specific AC-10 Antibody

Svetlana N. Rylova, Luigi Del Pozzo, Cathrin Klingeberg et al. · Journal of Nuclear Medicine · 2015 · 38 citations · Full text

Rows per page

1–5 of 12